ABVX (ABVX) Stock Price & Analysis
ABVX (ABVX) rose 0.66% to USD 114.79 as of September 8, 2026 at 06:21 UTC, according to Nexqual real-time market data.
ABVX last closed at USD 114.79; the session ranged USD 112.78–115.33 on volume of 489,816 shares. Market capitalization is —, with a 52-week range of USD 69.81–148.83 (NGM). Source: Nexqual, September 8, 2026 at 06:21 UTC.
Key Statistics (as of September 8, 2026 at 06:21 UTC)
| Price | USD 114.79 |
|---|---|
| Change | ▲ 0.66% (up) |
| Previous Close | USD 114.79 |
| Open | USD 114.79 |
| Day Range | USD 112.78 – 115.33 |
| 52-Week Range | USD 69.81 – 148.83 |
| Volume | 489,816 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (ABVX)
Nexqual's technical model rates ABVX "STRONG SELL" based on 0 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 06:21 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 40.02 (neutral) |
| vs SMA50 | Below (USD 125.15) |
| MACD | -3.08 (negative) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CELC | Celcuity Inc. | USD 95.7 | ▼ 0.52% |
| ALMS | Alumis Inc. | USD 11.1 | ▲ 7.25% |
| PRAX | Praxis Precision Medicines, Inc | USD 351.81 | ▼ 1.59% |
| TNGX | Tango Therapeutics, Inc. | USD 22.52 | ▲ 0.9% |
| GPCR | Structure Therapeutics Inc. | USD 47.34 | ▼ 0.96% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:21 UTC. This page is informational and not investment advice.